Correlation between a commercial SARS CoV 2 anti-spike RBD assay and neutralising antibody in the assessment of a functional antibody response in samples collected during a seroprevalence study in Ireland
Affiliation
Health Protection Surveillance Centre (HPSC)Issue Date
2024-02Keywords
COVID-19CORONAVIRUS
public health
TESTING
seropr
Metadata
Show full item record
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/